How Do You Spell NEONATAL ADRENOLEUKODYSTROPHY?

Pronunciation: [nˈiːə͡ʊnˌe͡ɪtə͡l ɐdɹˈɛnə͡ʊljˌuːkədˌɪstɹəfi] (IPA)

Neonatal Adrenoleukodystrophy (Ne-o-na-tal A-dre-no-lew-ko-dis-tro-phy) is a rare genetic disorder that affects newborns. The spelling of this word is based on the International Phonetic Alphabet (IPA) transcription, a system that represents the sounds of language. The word is divided into syllables and each syllable has a corresponding set of phonetic symbols. The correct spelling of this complex term is crucial for medical professionals as it is a life-threatening condition that requires early diagnosis and treatment.

NEONATAL ADRENOLEUKODYSTROPHY Meaning and Definition

  1. Neonatal Adrenoleukodystrophy (NALD) is a rare and severe genetic disorder that affects the metabolism and function of certain fats in the body. It falls under a broader spectrum of disorders known as peroxisomal disorders, which are characterized by abnormalities in the peroxisomes, the organelles responsible for breaking down various substances in the cells.

    NALD specifically affects infants from birth. It is caused by mutations in genes that encode for proteins involved in peroxisome function. These mutations impair the ability of peroxisomes to break down very long-chain fatty acids (VLCFAs), leading to an accumulation of these fatty acids in various tissues and organs.

    The buildup of VLCFAs has detrimental effects on the development and maintenance of the nervous system, particularly the myelin sheath, which insulates and protects nerve fibers. As a result, affected infants experience progressive deterioration of the white matter in the brain (leukodystrophy) and dysfunction of the adrenal glands.

    Symptoms of NALD include developmental delays, muscle weakness, vision and hearing problems, seizures, liver dysfunction, and hormonal abnormalities. The severity and rate of disease progression can vary among individuals, but NALD generally leads to profound disability and a reduced life expectancy.

    There is currently no cure for NALD, and treatment mainly focuses on managing the symptoms and complications associated with the disorder. This may involve medications, physical therapy, and supportive care.

    In summary, Neonatal Adrenoleukodystrophy is a rare and devastating peroxisomal disorder that affects newborns, leading to severe neurological and adrenal gland dysfunction due to the accumulation of very long-chain fatty acids.

Common Misspellings for NEONATAL ADRENOLEUKODYSTROPHY

  • beonatal adrenoleukodystrophy
  • meonatal adrenoleukodystrophy
  • jeonatal adrenoleukodystrophy
  • heonatal adrenoleukodystrophy
  • nwonatal adrenoleukodystrophy
  • nsonatal adrenoleukodystrophy
  • ndonatal adrenoleukodystrophy
  • nronatal adrenoleukodystrophy
  • n4onatal adrenoleukodystrophy
  • n3onatal adrenoleukodystrophy
  • neinatal adrenoleukodystrophy
  • neknatal adrenoleukodystrophy
  • nelnatal adrenoleukodystrophy
  • nepnatal adrenoleukodystrophy
  • ne0natal adrenoleukodystrophy
  • ne9natal adrenoleukodystrophy
  • neobatal adrenoleukodystrophy
  • neomatal adrenoleukodystrophy
  • neojatal adrenoleukodystrophy
  • neohatal adrenoleukodystrophy

Etymology of NEONATAL ADRENOLEUKODYSTROPHY

The word "Neonatal Adrenoleukodystrophy" (NALD) has the following etymology:

1. Neonatal: Derived from the Latin word "neonatus", meaning "newly born" or "recently born". It refers to the period immediately after birth. In medical terminology, it is often used to describe conditions or diseases that occur in the first 28 days of life.

2. Adrenoleukodystrophy:

- Adreno-: Derived from the Latin word "ad-, ad", meaning "near" or "towards". In medical terms, it is used to denote the adrenal glands.

- Leuko-: Derived from the Greek word "leukos", meaning "white". In medical terminology, it typically refers to the white matter in the brain and spinal cord.

Infographic

Add the infographic to your website: